Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Kuros Biosciences to share latest MagnetOs™ market impact and strategic…
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, May 13, 2025– Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, is pleased to announce today's Capital Markets Day on Tuesday, May 13, 2025, at 9am CEST, at the Hyatt Regency Zürich Airport, The Circle, Zürich, Switzerland. The event will also be available virtually via live webcast.Capital...
Nasdaq GlobeNewswire
13/05/2025
Ten-year APHINITY data show Roche's Perjeta-based regimen reduced the risk of…
Long term follow-up in this curative setting demonstrated clinically meaningful survival benefit when adding adjuvant Perjeta® (pertuzumab) to Herceptin® (trastuzumab) and chemotherapy 1 21% reduction in the risk of death was seen in the pre-specified subgroup of people with lymph node-positive disease 1 Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer CongressBasel, 13 May 2025 - Roche (SIX: RO, ROG; OTCQX:...
Nasdaq GlobeNewswire
13/05/2025
Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24…
Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24, 2025Halle (Saale) / Munich, Germany, May 13, 2025- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that its 2025 Annual General Meeting will be held on Tuesday, June 24, 2025 at 01:00 p.m...
Nasdaq GlobeNewswire
13/05/2025
IBA launches CASSY®, a new compact radiochemistry module to enhance efficiency…
Louvain-La-Neuve, Belgium, 13 May 2025- IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today announces the launch of CASSY ®, a compact synthesizer designed to streamline radiopharmaceutical production processes. This new IBA solution is set to transform the way radiometals and radiotracers are produced.CASSY ®, Compact Automated Scalable SYnthesis, enhances...
Nasdaq GlobeNewswire
13/05/2025
NMD Pharma to present compelling preclinical data highlighting the potential of…
NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on Myasthenia and Related DisordersThe Company continues to progress its Phase 2b clinical study in generalized myasthenia gravis (gMG) patients who are AChR and MuSK antibody positive, investigating the potential of NMD670 and its unique skeletal-muscle-targeted,...
Nasdaq GlobeNewswire
13/05/2025
Natura &Co Latam rebounds from last quarter and achieves 15% profitability in…
The Q1-25 results were driven by the Natura brand performance, which recorded a revenue increase of 8.2% in Brazil and 38.4% in the Hispanic countries (mid-teens excluding Argentina). In Brazil, robust retail growth was driven by strong same-store sales performance and a consistent pace of new store openings, reaching 149 owned stores (+34 compared to Q1-24) and 869 franchises (+88 compared to Q1-24). In digital, sales increased by 34.7% year-on-year, with the brand's share of voice on…
PR Newswire
13/05/2025
Chronic Pruritus Market is Anticipated to Expand at a CAGR of 8.6% During the…
Key Takeaways from the Chronic Pruritus Market Report Key Takeaways from the Chronic Pruritus Market Report Discover which therapies are expected to grab the major chronic pruritus market share @ Chronic Pruritus Market Report Chronic Pruritus Overview Chronic pruritus, defined as itching that persists for more than six weeks, can severely affect a person's quality of life and is linked to a variety of skin-related and systemic conditions. Its underlying mechanisms involve...
PR Newswire
12/05/2025
Cellectis Reports Financial Results for the First Quarter 2025
Lasme-cel (UCART22) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late 2025AstraZeneca partnership: R&D activities ongoing on three programs – one allogeneic CAR T for hematological malignancies, one allogeneic CAR T for solid tumors, and one in vivo gene therapy for a genetic disorderCellectis...
Nasdaq GlobeNewswire
12/05/2025
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and…
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody ®sonelokimab across portfolio of indications, including Phase 3 studies in hidradenitis suppurativa (HS), psoriatic Arthritis (PsA) and adolescent HS, as well as Phase 2 studies in palmoplantar pustulosis (PPP) and axial spondyloarthritis (axSpA)Announced completion of enrollment of patients in the...
Nasdaq GlobeNewswire
12/05/2025
Turning Pancakes into Purpose: A Puerto Rican Campaign Reshapes the Conversation…
Since its launch, over 200 restaurants in Puerto Rico joined the movement, including major brands like Burger King, IHOP, and Hungry Jack, generating a historic $1,124,994 in fundraising and a +1,763% increase in earned media. This achievement makes the campaign one of the most successful in SACCPR's history, both in visibility and fundraising. Since its launch, over 200 restaurants inPuerto Ricojoined the movement, including major brands likeBurger King,IHOP, andHungry Jack,...
PR Newswire
12/05/2025
IBA – ACQUISITION OF OWN SHARES
Immediate Release – May 12 th, 2025 Louvain-la-Neuve, Belgium, May 12 th, 2025 -In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24 th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of...
Nasdaq GlobeNewswire
12/05/2025
Fagron shareholders approve all voting items AGM
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 May 2025 – 7PM CET Fagron shareholders approve all voting items AGMFagron, the leading global player in pharmaceutical compounding, held its annual general shareholders meeting today, where all the voting items were approved. ResolutionsThe annual general meeting approved, amongst other things, Fagron's annual financial statements and dividend proposal of €0.35 per share for the fiscal year 2024, the...
Nasdaq GlobeNewswire
12/05/2025
IBA – TRANSPARENCY NOTIFICATION
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)Louvain-la-Neuve, Belgium, May 12 th, 2025 06:00 PM Summary of the notificationIBA (Ion Beam Applications), the world leader in particle accelerator technology, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on May 12 th, 2025...
Nasdaq GlobeNewswire
12/05/2025
SAFE Group - Successful first surgeries in Texas following purchase contract
Successful first surgeries in Texas following purchase contractFleurieux-sur-l'Arbresle-France – May 12, 2025, 6.00 p.m.Safe Group (FR001400F1V2 – ALSAF), a leader in innovative medical solutions, is proud to announce the successful completion of the first surgeries at a new facility in Texas, where Safe Orthopaedics and Spine Up solutions are newly referenced (see press release of March 12, 2025). These operations mark an important milestone in the deployment of Safe Group's...
Nasdaq GlobeNewswire
12/05/2025
Ipsen - April 2025 - Monthly information relative to the total number of voting…
Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1) 30 April 202583,814,526Gross total* ...
Nasdaq GlobeNewswire
12/05/2025
NTG Nordic Transport Group publishes interim report for Q1 2025
Company announcement no. 8 – 2512 May 2025 NTG Nordic Transport Group publishes interim report for Q1 2025The interim report for Q1 2025 is enclosed.In connection with publication of the results for Q1 2025, a conference call will be hosted on 13 May 2025 at 10:00 AM CEST.The conference call will be held in English and can be followed live via NTG's website ; investor.ntg.com. Additional information For additional information, please contact: Investor relations and press:...
Nasdaq GlobeNewswire
12/05/2025
Point Of Care Diagnostics Market Size to be $68.5 Billion by 2030 at CAGR 5.8% -…
Request a free sample copy or view report summary: Point Of Care Diagnostics Market Request a free sample copy or view report summary:Point Of Care Diagnostics Market Currently developed POC devices and tests are employed across different medical diagnostic applications, including cancer, pregnancy, and infectious diseases. Patients and physicians employ POC tests to screen conditions, confirm diagnoses, and design suitable therapeutic approaches based on patient health. However, the...
PR Newswire
12/05/2025
Orthodontic Supplies Market worth US$10.96 billion by 2030 with 8.9% CAGR |…
As disposable incomes rise, more people can afford orthodontic treatments, further fueling market growth. Moreover, there is an increasing public awareness of the importance of oral health. As disposable incomes rise, more people can afford orthodontic treatments, further fueling market growth. Moreover, there is an increasing public awareness of the importance of oral health. Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236529189 Browse in-depth TOC...
PR Newswire
12/05/2025
Care Begins Within Because Ingredients Matter: Lenzing's VEOCEL™ Champions…
At both events, VEOCEL™ demonstrated how its Lyocell fibers, derived from sustainably managed wood sources[1], a renewable raw material, can unlock new potential for manufacturers looking to shift away from fossil-based synthetics. Biodegradable[2] and produced through a closed-loop, resource-efficient process with low environmental impact, and low emissions to air and water[3], VEOCEL™ Lyocell represents a powerful cellulosic solution for a wide range of single-use applications. At both...
PR Newswire
12/05/2025
Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US…
Piramal Pharma's Riverview, Michigan site, has earned a reputation as an industry leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs) over the past 50+ years. Here, the company is adding a commercial-scale suite specifically for the development and manufacturing of payload-linkers. These high potency APIs are used in the development of antibody-drug conjugates (ADCs) and other bioconjugate drugs. The new payload-linker suite…
PR Newswire
12/05/2025
ASEAN Point of Care Diagnostics Market worth $1.36 billion by 2030 with 4.7%…
Browse in-depth TOC on 'ASEAN Point of Care Diagnostics Market'269 - Tables51 - Figures335 - Pages Browse in-depth TOC on 'ASEAN Point of Care Diagnostics Market' 269 - Tables 51 - Figures 335 - Pages By Based on product,the ASEAN point of care diagnostics market is segmented into infectious disease testing products, glucose monitoring products, cardiometabolic testing products, coagulation monitoring products, pregnancy & fertility testing products, urinalysis testing...
PR Newswire
12/05/2025
Transactions in Connection with Share Buy-back Program
Company Announcement COPENHAGEN, Denmark; May 12, 2025 – Genmab A/S (Nasdaq: GMAB).On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025.The following transactions were executed under the program from May 5 to May 9, 2025: Trading PlatformNo...
Nasdaq GlobeNewswire
12/05/2025
Kimera® Labs Named Semifinalist in $101 Million XPRIZE Healthspan Competition…
The original XPRIZE, awarded in 2004, created a new model for solving big challenges in an open, incentive-based competition. By offering $10 million for private spaceflight, it sparked the commercial space industry and proved that bold goals, clear rules, and global participation could drive breakthrough innovation across any field. The original XPRIZE, awarded in 2004, created a new model for solving big challenges in an open, incentive-based competition. By offering$10 millionfor private...
PR Newswire
12/05/2025
Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical…
EU certification supports deployment in multiple global markets and once commercialised, will enable healthcare professionals to recommend the device offered by Curaleaf International in countries including European countries, the UK, Canada, and regions across Australasia. EU certification supports deployment in multiple global markets and once commercialised, will enable healthcare professionals to recommend the device offered by Curaleaf International in countries including European...
PR Newswire
12/05/2025
Altri Comunicati
